Ohio State University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Ohio State University sits in the top decile of US sponsors by registered trial count (#66 of 15,742 sponsors by registered trial count).

552 total trials 117 currently recruiting 319 completed early-phase tilt top decile by trial count

Ohio State University: 552 sponsored US clinical trials, 117 recruiting.

Ohio State University sponsors 552 registered US clinical trials on ClinicalTrials.gov, 117 of them currently recruiting, and 319 completed. 39 of these trials are in Phase 3-4 (later-stage) and 60 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Suicidal Ideation, with 8 trials.

Top-decile sponsor footprint

Ohio State University ranks in the top decile of sponsors by registered trial count (#66 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 57/100

319 of 366 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

552 total, page 7 of 12

COMPLETED NA

Feasibility of Collecting Stress Biomarkers Among Youth Experiencing Homelessness

NCT04004520

COMPLETED NA

Cooking Matters for Diabetes - A 6-Week Program for Practical Application of Diabetes Self-Management Education

NCT04152811

COMPLETED NA

Gut-level Antiinflammatory Activities of Green Tea in Metabolic Syndrome

NCT03973996

COMPLETED NA

Alleviation Of Metabolic Endotoxemia In Adults With Metabolic Syndrome With Milk Fat Globule Membrane

NCT03860584

TERMINATED NA

Hill-Rom WAVE for Positional Obstructive Sleep Apnea at Home

NCT03971721

COMPLETED NA

Feasibility of Action Observation and Repetitive Task Practice on Upper Extremity Outcomes in Chronic Stroke Survivors

NCT04015271

COMPLETED NA

Evaluation of the Prenatal Trip Assistance Pilot Project

NCT03956810

COMPLETED NA

Robotic Walking Device to Improve Mobility in Parkinson's Disease

NCT03751371

COMPLETED NA

Impact of Omega-3 Fatty Acid Oral Therapy on Healing of Chronic Venous Leg Ulcers in Older Adults

NCT03576989

COMPLETED NA

Dietary Supplementation in Heart Failure

NCT03980574

COMPLETED Phase 2

Utilization of Hepatitis C Positive Kidneys in Negative Recipients

NCT03801707

TERMINATED Phase 4

Postpartum Family Planning

NCT03844633

TERMINATED NA

Transcranial Direct Current Stimulation Therapy for Sleepiness Related to Shift Work Disorder (tDCS-SWORD)

NCT03879044

COMPLETED Phase 2

Subcutaneous Methylnaltrexone Versus Placebo for Postoperative Ileus Prevention

NCT03852524

TERMINATED NA

Single-Armed Use of ViviGen Cellular Bone Matrix in Patients Undergoing Posterolateral Lumbar Surgery

NCT04007094

TERMINATED Phase 4

The Effect of Two Aspirin Dosing Strategies for Obese Women at High Risk for Preeclampsia

NCT03735433

COMPLETED NA

The Effect of the Low Fodmap Diet in Children With Autism Spectrum Disorders

NCT04054349

COMPLETED NA

Tear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye Drops

NCT03706443

COMPLETED

Predicting the Development of Myocardial Depression in Acute Neurological Patients

NCT03801694

COMPLETED NA

Evaluating The Efficacy Of A Mind-Body Intervention In Overcoming Opioid Addiction

NCT03791645

COMPLETED NA

Reiki Intervention for Seriously Ill Elders Intensive Care Unit (RISE-ICU)

NCT03685760

COMPLETED Early Phase 1

Intravenous and Perineural Dexamethasone for Brachial Plexus Block in Hand Surgery

NCT03512223

COMPLETED Phase 4

Vaginal Estrogen on Postpartum Atrophy, Perineal Pain, and Sexual Function

NCT03493126

COMPLETED

Adults With SMA Treated With Nusinersen

NCT04591678

TERMINATED Phase 1

Lenalidomide in Anti-MAG Neuropathy: Phase 1b Study

NCT03701711

COMPLETED NA

Dietary Green Tea Confection For Resolving Gut Permeability-Induced Metabolic Endotoxemia In Obese Adults

NCT03413735

COMPLETED NA

Brain Connections and Blood Pressure

NCT03736434

COMPLETED NA

Lumbar Fusion With Nexxt Spine 3D-Printed Titanium Interbody Cages

NCT03647501

COMPLETED NA

Mind-body Interventions for Healthy Aging

NCT03626532

COMPLETED NA

Cardiometabolic Benefits of Potatoes Mediated Along the Gut-Vessel Axis in Adults With Metabolic Syndrome

NCT03624569

COMPLETED Phase 1

The Effect of Sugammadex Versus Neostigmine During Neuromuscular Blockade Reversal

NCT03579589

COMPLETED

Motor Unit Number Estimation (MUNE) in Adults With Spinal Muscular Atrophy (SMA)

NCT04139343

COMPLETED NA

Feasibility and Preliminary Efficacy of Support Figure Attendance at Bariatric Patients' Clinical Visits

NCT03642197

COMPLETED NA

Load Modification Versus Standard Exercise for Greater Trochanteric Pain Syndrome

NCT03571971

COMPLETED NA

Impact of Exogenous Ketones on Indices of Keto-Adaptation in Obese Subjects on Weight Reducing Diets.

NCT06449287

COMPLETED

The Effect of Histopathologic Analysis and Tissue Cultures on Inpatient Management of Cellulitis and Pseudocellulitis

NCT03785834

TERMINATED NA

Effectiveness of a Diabetes Focused Discharge Order Set Among Poorly Controlled Hospitalized Patients Transitioning to Glargine U300 Insulin

NCT03455985

TERMINATED

Risk Factors for Complications After Carotid Endarterectomy

NCT03788980

COMPLETED NA

Healthy Lifestyle Intervention for High-Risk Minority Pregnant Women

NCT03416010

TERMINATED NA

Nonarthritic Hip Disease Evaluation And Treatment

NCT03519087

COMPLETED NA

Vidatalk Communication Application: Usability, Acceptability and Efficacy Study

NCT02921776

COMPLETED

Synaptic Injury and Functional Connectivity in Alzheimer's Disease

NCT03300726

COMPLETED NA

Augmented Care at Worksite for Diabetes Prevention

NCT03382873

TERMINATED

Opioid Consumption in Cystectomy Patients

NCT03032822

COMPLETED NA

Postoperative Delirium in Patients Undergoing Radical Cystectomy

NCT03132168

COMPLETED NA

Metabolic Health in Individuals With Spinal Cord Injury (SCI)

NCT03204240

COMPLETED NA

Increasing Adherence to Oral Appliance Therapy for Obstructive Sleep Apnea

NCT05038215

COMPLETED NA

Proposal for Intraoperative Administration of Intravenous Indocyanine Green to Evaluate Position of the Optic Canal, Position of the Internal Carotid Arteries, Tumor Vascularization, and Vessel Encasement in Endoscopic Endonasal Cranial Base Surgery

NCT03072186

COMPLETED NA

Behavior and Activity Monitoring in MS

NCT03244696

COMPLETED NA

Low Carbohydrate/High Protein Diet to Improve Metabolic Health

NCT03207841

← Previous Page 7 of 12 Next →

Phase Distribution

PhaseTrial count
Phase 1 35
Phase 2 25
Phase 3 5
Phase 4 34

What is open in the Ohio State University pipeline

117 recruiting of 552 indexed (21% open); 319 completed (58%).

Phase mix: 39 late (III/IV) vs 60 early (I/II) (early-phase heavy).

Top condition: Suicidal Ideation (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Ohio State University: open-pipeline peers nationwide

Peers matched on 552 registered trials and 21% open enrollment, not the therapeutic-area sidebar.

Ohio State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600 5%10%15%20%25% Total trials Recruiting share Ohio State UniversityAmgenMerck Sharp & DohmeVirginia Commonwealth UniversityOregon Health and Science UniversityUniversity of LouisvilleMedical College of WisconsinNova Southeastern UniversityColorado State University
Ohio State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Ohio State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 552 trials (± recruiting share)

Sponsors near 21% open enrollment (± trial volume)

What to do with this Ohio State University page

552 registered trials is a research-attention snapshot, not an endorsement of Ohio State University or any single study.

  • 117 of Ohio State University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Suicidal Ideation is the condition Ohio State University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Suicidal Ideation trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Ohio State University pipeline card: 552 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.